A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

David B Clemow,1 Chris Bushe,2 Michele Mancini,3 Michael H Ossipov,4 Himanshu Upadhyaya1 1Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly, Windlesham, UK; 3Eli Lilly Italia S.p.A., Sesto Fiorentino, Italy; 4inVentiv Health Clinical, LLC, Blue Bell, PA, USA Abstract: Attention-deficit hype...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Clemow DB, Bushe C, Mancini M, Ossipov MH, Upadhyaya H
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	Atomoxetine attention-deficit hyperactivity disorder comorbid psychiatric disorders juvenile attention-deficit hyperactivity disorder adult attention-deficit hyperactivity disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/263f729772de4a7fa846bffae8a40a3f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

Documents similaires